S. Channon

发表

Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF.

C. Scrimgeour, C. Hetherington, T. Goodship, 1995, The American journal of physiology.

Correction of acidosis in CAPD decreases whole body protein degradation.

S. Downie, T. Goodship, J. Passlick–Deetjen, 1996, Kidney international.

Correction of acidosis in hemodialysis decreases whole-body protein degradation.

S. Downie, T. Goodship, D. Reaich, 1997, Journal of the American Society of Nephrology : JASN.

Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans.

C. Scrimgeour, T. Goodship, D. Reaich, 1992, The American journal of physiology.

Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.

A. Morley, T. Lennard, M. Laker, 1988, Journal of clinical pathology.

Raised serum nickel concentrations in chronic renal failure.

D. Kerr, M. Ward, S. Channon, 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

1% amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease.

S. Arfeen, T. Goodship, A. Kirkwood, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation.

C. Scrimgeour, T. Goodship, S. Daley, 1993, The American journal of physiology.

Aluminium transfer during hemodialysis and its relation to serum ultrafiltrable aluminium

D. Kerr, M. Ward, S. Channon, 1985 .

Methods for studying the binding of aluminum by serum protein.

D. Kerr, M. Ward, S. Channon, 1985, Clinical chemistry.

Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility.

M. Ward, M. Laker, S. Channon, 1989, Clinica chimica acta; international journal of clinical chemistry.

Ascorbate‐induced hyperoxalaemia has no significant effect on lactate generation or erythrocyte 2,3, diphosphoglycerate in dialysis patients

M. Laker, S. Channon, C. Tomson, 1990, European journal of clinical investigation.

The determination of plasma oxalate concentrations using an enzyme/bioluminescent assay. 2. Co-immobilisation of bioluminescent enzymes and studies of in vitro oxalogenesis.

C. Tomson, M. Ward, M. Laker, 1989, Clinica chimica acta; international journal of clinical chemistry.

Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.

J. M. Simpson, J. Owen, M. Ward, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A method for the determination of nickel in water and serum by flameless atomic absorption spectrophotometry.

D. Kerr, M. Ward, S. Channon, 1985, Clinica chimica acta; international journal of clinical chemistry.

The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease.

S. Channon, A. Lees, M. Youdim, 1995, Journal of clinical psychopharmacology.

Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.

M. Ward, M. Laker, S. Channon, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.